Re: COVID-19 mortality among selective serotonin reuptake inhibitor users by Stauning et al

Clin Microbiol Infect. 2024 Jun;30(6):836-837. doi: 10.1016/j.cmi.2024.02.007. Epub 2024 Feb 10.

Authors

Carla P Rus¹, J J Sandra Kooij²

Affiliations

¹ Independent Researcher. Electronic address: rusvries@ziggo.nl.
² Department of Psychiatry, VU University Medical Center, Expertise Center Adult ADHD, Amsterdam, The Netherlands; Expertise Center Adult ADHD, PsyQ, The Hague, The Netherlands.

PMID: 38346536
DOI: 10.1016/j.cmi.2024.02.007

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / mortality
Humans
SARS-CoV-2
Selective Serotonin Reuptake Inhibitors* / therapeutic use

Substances

Selective Serotonin Reuptake Inhibitors